​

Teladoc Health (TDOC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

TDOC Stock Forecast

Teladoc Health (TDOC) stock forecast, based on 42 Wall Street analysts, predicts a 12-month average price target of $7.13, with a high of $8.50 and a low of $6.00. This represents a 39.80% increase from the last price of $5.10.

$5 $9 $13 $17 $21 $25 High: $8.5 Avg: $7.13 Low: $6 Last Closed Price: $5.1

TDOC Stock Rating

Teladoc Health stock's rating consensus is Hold, based on 42 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 14 Buy (33.33%), 28 Hold (66.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 42 28 14 0 Strong Sell Sell Hold Buy Strong Buy

TDOC Price Target Upside V Benchmarks

TypeNameUpside
StockTeladoc Health39.80%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Information Services Stocks 43.76%

Price Target Trends

1M3M12M
# Anlaysts257
Avg Price Target$6.00$7.50$7.93
Last Closing Price$5.10$5.10$5.10
Upside/Downside17.65%47.06%55.49%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 261521--27
Feb, 261422--27
Jan, 261422--27
Dec, 251421--26
Nov, 251420--25
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 26, 2026David GrossmanStifel Nicolaus$6.00$5.0718.34%17.65%
Feb 26, 2026Stephen BaxterWells Fargo$6.00$4.6529.03%17.65%
Jan 16, 2026Goldman Sachs$8.00$6.5322.51%56.86%
Jan 09, 2026David RomanGoldman Sachs$9.00$7.6118.27%76.47%
Dec 08, 2025Barclays$8.50$7.5612.43%66.67%
Oct 30, 2025David GrossmanStifel Nicolaus$8.00$8.82-9.30%56.86%
Jul 30, 2025Raymond James$10.00$7.4035.14%96.08%
Dec 04, 2024Jessica TassanPiper Sandler$13.00$11.0118.07%154.90%
Oct 31, 2024Daniel GrosslightCitigroup$11.00$8.8624.15%115.69%
Oct 30, 2024Elizabeth AndersonEvercore ISI$9.00$8.861.58%76.47%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 26, 2026Bank of America SecuritiesNeutralBuyupgrade
Feb 26, 2026NeedhamBuyBuyhold
Jan 09, 2026CitigroupNeutralNeutralhold
Jan 09, 2026Goldman SachsBuyBuyhold
Jan 05, 2026Bank of America SecuritiesNeutralNeutralhold
Dec 08, 2025BarclaysOverweightNeutralinitialise
Oct 21, 2025CitigroupNeutralNeutralhold
Jul 30, 2025Cantor FitzgeraldOverweightOverweighthold
Dec 04, 2024Piper SandlerOverweightOverweighthold
Oct 31, 2024Cowen & Co.HoldHoldhold

Financial Forecast

EPS Forecast

$-85 $-67 $-49 $-31 $-13 $5 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.73$-84.60$-1.36$-5.87$-1.14---
Avg Forecast$-3.25$-61.26$-1.38$-5.82$-0.89$-0.80$-0.63$-0.03
High Forecast$-3.04$-58.91$-0.99$-5.64$-0.50$-0.08$0.47$-0.02
Low Forecast$-3.42$-63.04$-1.45$-5.94$-1.23$-1.20$-1.11$-0.03
Surprise %-16.00%38.10%-1.45%0.86%28.09%---

Revenue Forecast

$2B $2B $2B $2B $3B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.03B$2.41B$2.60B$2.57B$2.53B---
Avg Forecast$2.03B$2.40B$2.61B$2.57B$2.55B$2.59B$2.66B$2.75B
High Forecast$2.11B$2.46B$2.62B$2.60B$2.61B$2.59B$2.66B$2.82B
Low Forecast$1.92B$2.33B$2.51B$2.55B$2.41B$2.58B$2.66B$2.64B
Surprise %0.35%0.18%-0.39%0.04%-0.60%---

Net Income Forecast

$-550B $-430B $-310B $-190B $-70B $50B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-428.79M$-13.66B$-220.37M$-1.00B$-200.32M---
Avg Forecast$-385.89M$-434.22B$-220.37M$-953.23M$-156.71M$-148.59M$-92.16M$-4.11M
High Forecast$-308.71M$-347.37B$-176.29M$-928.45M$-81.96M$-12.97M$77.75M$-3.90M
Low Forecast$-463.07M$-521.06B$-264.44M$-978.01M$-201.87M$-197.67M$-182.81M$-4.24M
Surprise %11.12%-96.85%-5.04%27.83%---

TDOC Forecast FAQ

Is Teladoc Health stock a buy?

Teladoc Health stock has a consensus rating of Hold, based on 42 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 14 Buy, 28 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Teladoc Health is a neutral investment for most analysts.

What is Teladoc Health's price target?

Teladoc Health's price target, set by 42 Wall Street analysts, averages $7.13 over the next 12 months. The price target range spans from $6 at the low end to $8.5 at the high end, suggesting a potential 39.80% change from the previous closing price of $5.1.

How does Teladoc Health stock forecast compare to its benchmarks?

Teladoc Health's stock forecast shows a 39.80% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the healthcare information services stocks industry (43.76%).

What is the breakdown of analyst ratings for Teladoc Health over the past three months?

  • March 2026: 3.70% Strong Buy, 18.52% Buy, 77.78% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 3.70% Strong Buy, 14.81% Buy, 81.48% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 3.70% Strong Buy, 14.81% Buy, 81.48% Hold, 0% Sell, 0% Strong Sell.

What is Teladoc Health’s EPS forecast?

Teladoc Health's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.8, marking a -29.82% decrease from the reported $-1.14 in 2025. Estimates for the following years are $-0.63 in 2027, and $-0.03 in 2028.

What is Teladoc Health’s revenue forecast?

Teladoc Health's average annual revenue forecast for its fiscal year ending in December 2026 is $2.59B, reflecting a 2.27% increase from the reported $2.53B in 2025. The forecast for 2027 is $2.66B, and $2.75B for 2028.

What is Teladoc Health’s net income forecast?

Teladoc Health's net income forecast for the fiscal year ending in December 2026 stands at $-149M, representing a -25.83% decrease from the reported $-200M in 2025. Projections indicate $-92.161M in 2027, and $-4.114M in 2028.